Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-10-15

Clinical Trial Update: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction [NA]

View source ↗

Summary

This clinical trial update shows that a study evaluating the cardioprotective effect of dexmedetomidine in STEMI patients undergoing PCI is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Harbin Medical University | Conditions: ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention | NA | Status: RECRUITING